Hadassah continues leading-edge research in breast cancer detection
Hadassah’s findings have had a major impact on breast cancer management.
Hadassah’s findings have had a major impact on breast cancer management.
The research findings could lead to new cancer-fighting therapies
Researchers at the Hadassah Medical Center and Hebrew University have found that the most common form of white blood cells, called neutrophils, contain at least three distinct subtypes. Some fight the development of cancer, while others provide a hospitable environment for their growth.
Breaking new ground for MRI imaging in diagnosing cancerous lesions and observing the body in real time as it metabolizes various molecules, Hadassah’s Center for Hyperpolarized MRI Molecular Imaging is an innovator in its domain. Using a technique called hyperpolarization, the Center is able to increase the sensitivity of an MRI scan 10,000 fold.
Melanoma is the most deady of skin cancers!
Signs to watch for with “spots” that indicate that they may be dangerous include:
Prep Your Skin for Summer
The American society of aesthetic surgeons, the organization of board certified cosmetic plastic surgeons, provides ready made blogs for their members and since this one has particularly good links in it, I am utilizing the benefits of my membership fee and letting you read what they say about protecting your skin in the summer!
With a world-first placental stem-cell (PLX) treatment, developed by Pluristem, doctors at the Hadassah University Medical Center have saved the life of a third patient suffering from bone marrow disease.
A new method for operating on liver cancer patients was put to the test for the first time in Israel recently at Hadassah University Hospital-Ein Kerem in Jerusalem. The method applies a direct flow of high-voltage electrical currents to the malignant tumor and has raised new hope for patients diagnosed with the disease.
PRESS RELEASE
Hadassah University Hospital Makes Lung Cancer Breakthroughs
Yet another success in the area of cancer treatment for Israeli researchers
PRESS RELEASE
Tailored to treat 90 percent of cancers
Hadassah University Medical Center performing clinical trials for vaccine that can kill cancer
The Hadassah University Medical Center in Jerusalem is currently in advanced clinical trials for a therapeutic vaccine, ImMucim, that has been formulated to ‘train’ the immune system to seek and destroy malignant cells that have already invaded the body. Principal investigator in these clinical trials is Dr. Michael Y Shapira, MD, of Hadassah.